Azra Raza - Concepedia

Author

Azra Raza

Roswell Park Comprehensive Cancer Center ORCID

Also Known As

A Raza, A. RAZA, A. Raza, AZRA RAZA, Azra Raza, Bennet J. McComish, Dr. Azra Raza, Huang, X.-P, Raza, Azra, Ronald Paquette

440

Publications

20.4K

Citations

H-Index

103

Concepts

All Affiliations

Roswell Park Comprehensive Cancer Center Columbia University Irving Medical Center Rush University Medical Center The University of Texas MD Anderson Cancer Center Cornell University

About

Azra Raza is an author at Roswell Park Comprehensive Cancer Center specializing in medicine, hematology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	73	3.6K
2	Health Sciences	16	20	1K
3	Natural Sciences	3	3	273
4	Public Health	2	2	113
5	Engineering	1	1	205

Azra Raza

175

Publications

18.6K

Citations

H-Index

Page 1

	Year	Citations
A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis Srđan Verstovšek, Ruben A. Mesa, Jason Gotlib, New England Journal of Medicine	2012	2K
Clinical Effect of Point Mutations in Myelodysplastic Syndromes Rafael Bejar, Kristen E. Stevenson, Omar Abdel‐Wahab, New England Journal of Medicine	2011	1.6K
Decitabine improves patient outcomes in myelodysplastic syndromes Hagop M. Kantarjian, Jean‐Pierre J. Issa, C Rosenfeld, Cancer	2006	1.5K
Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion Alan F. List, Gordon W. Dewald, John M. Bennett, New England Journal of Medicine	2006	1.3K
Identification of RPS14 as a 5q- syndrome gene by RNA interference screen Benjamin L. Ebert, Jennifer Pretz, Jocelyn Bosco, Nature	2008	910
Myelodysplastic syndromes Xiaomei Ma, Monique B. Does, Azra Raza, Cancer	2007	538
Leukaemogenesis induced by an activating β-catenin mutation in osteoblasts Aruna Kode, John S. Manavalan, Ioanna Mosialou, Nature Cell Biologyβ-Catenin MutationBone Morphogenic Protein	2014	508
Validation of a Prognostic Model and the Impact of Mutations in Patients With Lower-Risk Myelodysplastic Syndromes Rafael Bejar, Kristen E. Stevenson, Bennett Adam Caughey, Journal of Clinical Oncology	2012	437
Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes [see comments] Azra Raza, Sefer Gezer, Suneel Mundle, Blood	1995	430
Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1–risk myelodysplastic syndromes with karyotypes other than deletion 5q Azra Raza, James A. Reeves, Eric J. Feldman, Blood	2007	422

Page 1